Inhibition of acetylcholinesterase by two arylderivatives: 3a-Acetoxy-5H-pyrrolo(1,2-a) (3,1)benzoxazin-1,5-(3aH)-dione and cis-N-p-Acetoxy-phenylisomaleimide

References

• Terry AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 2003; 306: 821–828
   PubMed Web of Science ®Google Scholar
• Bourne Y, Grassi J, Bougis PE, Marchot P. Conformational flexibility of the acetylcholinesterase tetramer suggested by x-ray crystallography. J Biol Chem 1999; 274: 30370–30376
   PubMed Web of Science ®Google Scholar
• Evans JG, Wilcock G, Birks J. Evidence-based pharmacotherapy of Alzheimer's disease. Int J Neuropsychopharmacol 2004; 7: 351–369
   PubMed Web of Science ®Google Scholar
• McGleenon BM, Dynan KB, Passmore AP. Acetylcholinesterase inhibitors in Alzheimer's disease. Br J Clin Pharmacol 1999; 48: 471–480
   PubMed Web of Science ®Google Scholar
• Thompson S, Lanctot KL, Herrmann N. The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert Opin Drug Safety 2004; 3: 425–440
   PubMedGoogle Scholar
• Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271: 992–998
   Google Scholar
• Bryant CA, Ouldred E, Jackson SH, Kinirons MT. Purpuric rash with donepezil treatment. Br Med J 1998; 317: 787
   PubMedGoogle Scholar
• Hossain M, Jhee SS, Shiovitz T, McDonald C, Sedek G, Pommier F, Cutler NR. Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type. Clin Pharmacokinet 2002; 41: 225–234
   PubMed Web of Science ®Google Scholar
• Trujillo-Ferrara J, Vázquez I, Espinosa J, Santillán R, Farfán N, Höpfl H. Reversible and irreversible inhibitory activity of succinic and maleic acid derivatives on acetylcholinesterase. Eur J Pharm Sci 2003; 18: 313–322
   PubMed Web of Science ®Google Scholar
• Trujillo-Ferrara J, Montoya Cano L, Espinoza-Fonseca M. Synthesis, anticholinesterase activity and structure-activity relationships of m-aminobenzoic acid derivatives. Bioorg Med Chem Lett 2003; 13: 1825–1827
   PubMed Web of Science ®Google Scholar
• Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U.S.A. 1993; 90: 9031–9035
   PubMed Web of Science ®Google Scholar
• Trujillo-Ferrara J, Correa-Basurto J, Espinosa J, García J, Martínez F, Miranda R. Solvent-Free Synthesis of Arylamides and Arylimides Analogues of Acetylcholine. Synth Commun 2005; 35: 2017–2023
   Web of Science ®Google Scholar
• Hargreaves MK, Pritchard JG. Dave HR. Cyclic carboxylic monoimides. Chem Rev 1970; 70: 439–469
   Web of Science ®Google Scholar
• Balsubramaniyan V, Argade NP. Reactions of cyclic anhydrides XI. A Facile approach to pyrrolo-3, 1-benzoxazinones via anilic acids. Tetrahedron 1983; 39: 2487–2488
   Google Scholar
• Barba V, Hernández C, Rojas-Lima S, Farfan N. Santillan R. Preparation of N-aryl-substituted spiro-β-lactams via Staudinger cycloaddition. Can J Chem 1999; 77: 2025–2032
   Web of Science ®Google Scholar
• Bonting SL, Featherstone RM. Ultramicro assay of the cholinesterases. Arch Biochem Biophys 1956; 61: 89–98
   PubMed Web of Science ®Google Scholar
• Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling. Electrophoresis 1997; 18: 2714–2723
   PubMed Web of Science ®Google Scholar
• Pedretti A, Villa L, Vistoli G. VEGA: A versatile program to convert, handle and visualize molecular structure on Windows-based PCs. J Mol Graph 2002; 21: 47–49
   Google Scholar
• Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson A. Automated Docking Using a Lamarckian Genetic Algorithm and and Empirical Binding Free Energy Function. J Comp Chem 1998; 19: 1639–1662
   Web of Science ®Google Scholar
• Kitz R, Wilson IB. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem 1962; 237: 3245–3249
   PubMed Web of Science ®Google Scholar
• Abeles RH, Maycock AL. Suicide enzyme inactivators Acc. Chem Res 1976; 9: 313–319
   Web of Science ®Google Scholar
• Zaheer-Ul-Haq ZU, Wellenzohn B, Liedl KR, Rode BM. Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna. J Med Chem 2003; 46: 5087–5090
   PubMed Web of Science ®Google Scholar
• Zeng F, Jiang H, Zhai Y, Zhang H, Chen K, Ji R. Synthesis and acetylcholinesterase inhibitory activity of huperzine A-E2020 combined compound. Bioorg Med Chem Lett 1999; 9: 3279–3284
   PubMed Web of Science ®Google Scholar
• Correa-Basurto J, Vázquez-Alcántara I, Espinoza-Fonseca ML, Trujillo-Ferrara JG. p-Aminobenzoic. acid derivatives as acetylcholinesterase inhibitors. Eur J Med Chem 2005; 40: 732–735
   PubMed Web of Science ®Google Scholar